Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.2%

3 terminated/withdrawn out of 247 trials

Success Rate

94.3%

+7.8% vs industry average

Late-Stage Pipeline

13%

31 trials in Phase 3/4

Results Transparency

4%

2 of 50 completed trials have results

Key Signals

58 recruiting2 with results

Enrollment Performance

Analytics

N/A
82(58.2%)
Phase 4
23(16.3%)
Phase 2
19(13.5%)
Phase 3
8(5.7%)
Early Phase 1
6(4.3%)
Phase 1
3(2.1%)
141Total
N/A(82)
Phase 4(23)
Phase 2(19)
Phase 3(8)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (247)

Showing 20 of 247 trials
NCT07643922Not ApplicableNot Yet Recruiting

Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage

Role: collaborator

NCT07620626Recruiting

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Role: collaborator

NCT07640490Early Phase 1Completed

Influence of Oral Probiotics on Anxiety and Depression in Adolescents After Non-cardiac and Non-gastrointestinal Surgeries: A Prospective, Double-blind, Placebo-controlled Study

Role: lead

NCT07630922Not ApplicableCompleted

Influence of Intraoperative Auditory Intervention on Emergence Delirium in Preschoolers: A Randomised Controlled Clinical Trial

Role: lead

NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT06261996Not ApplicableCompleted

Safety and Efficacy of Fospropofol vs Propofol During Invasive Mechanical Ventilation.

Role: lead

NCT07614594Recruiting

Noninvasive Urine Testing for Urothelial Carcinoma

Role: lead

NCT05129904Active Not Recruiting

Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)

Role: collaborator

NCT07002346Phase 3Recruiting

INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma

Role: collaborator

NCT07586813Phase 2Recruiting

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors

Role: collaborator

NCT07586787Not ApplicableRecruiting

Early Vitrectomy vs PRP in Early Proliferative Diabetic Retinopathy

Role: collaborator

NCT07586826Phase 2Recruiting

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

Role: collaborator

NCT07484867Completed

Effect of CYP2D6*10 Gene Mutation on Perioperative Precision Analgesia of Oxycodone in Elderly Patients

Role: lead

NCT03385902Not ApplicableCompleted

Assessment of Dialysis Initiation by a Fuzzy Mathematics Equation

Role: collaborator

NCT06284642Phase 4Recruiting

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Role: collaborator

NCT07390929Not ApplicableWithdrawn

Clinical Trial Study on the Improved New Method of Acupotomy for AS

Role: lead

NCT06538883Not ApplicableRecruiting

Sedation in ICU Patients With Mechanical Ventilation

Role: collaborator

NCT06741839Not ApplicableRecruiting

Confocal Laser Endomicroscopy Guided Medical Thoracoscopy for the Diagnosis of Pleural Disease

Role: collaborator

NCT06790810Completed

Observational Study on Dynamic Changes of Blood Pressure During Post-epileptic Seizure Stage (OCBPS)

Role: collaborator

NCT06737913Phase 2Recruiting

HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma

Role: collaborator